Literature DB >> 28611124

Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model.

Andreas B Gevaert1, Hadis Shakeri2, Arthur J Leloup2, Cor E Van Hove2, Guido R Y De Meyer2, Christiaan J Vrints2, Katrien Lemmens2, Emeline M Van Craenenbroeck2.   

Abstract

BACKGROUND: Because of global aging, the prevalence of heart failure with preserved ejection fraction (HFpEF) continues to rise. Although HFpEF pathophysiology remains incompletely understood, endothelial inflammation is stated to play a central role. Cellular senescence is a process of cellular growth arrest linked with aging and inflammation. We used mice with accelerated aging to investigate the role of cellular senescence in HFpEF development. METHODS AND
RESULTS: Senescence-accelerated mice (SAM, n=18) and control mice with normal senescence (n=15) were fed normal chow or a high-fat, high-salt diet (WD). Vascular and cardiac function was assessed at 8, 16, and 24 weeks of age. At 24 weeks, both SAM on WD (SAM-WD) and SAM on regular diet displayed endothelial dysfunction, as evidenced by impaired acetylcholine-induced relaxation of aortic segments and reduced basal nitric oxide. At week 24, SAM-WD had developed HFpEF, characterized by diastolic dysfunction, left ventricular hypertrophy, left atrial dilatation, and interstitial fibrosis. Also, exercise capacity was reduced and lung weight increased. Cardiovascular inflammation and senescence were assessed by immunohistochemical and immunofluorescence staining of hearts and aortas. SAM-WD showed increased endothelial inflammation (intercellular adhesion molecule 1 expression) and increased endothelial senescence (acetyl-p53/CD31 costaining). The latter correlated with diastolic function and intercellular adhesion molecule 1 expression.
CONCLUSIONS: SAM develop endothelial dysfunction. Adding a high-salt, high-fat diet accelerates endothelial senescence and instigates endothelial inflammation. This coincides with hemodynamic and structural changes typical of HFpEF. Targeting endothelial senescence could be a new therapeutic avenue in HFpEF.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  aging; endothelium; heart failure; heart failure with preserved ejection fraction; senescence

Mesh:

Year:  2017        PMID: 28611124     DOI: 10.1161/CIRCHEARTFAILURE.116.003806

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  45 in total

Review 1.  Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.

Authors:  Heng Zeng; Jian-Xiong Chen
Journal:  J Cardiovasc Pharmacol       Date:  2019-10       Impact factor: 3.105

Review 2.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

3.  Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.

Authors:  Kathryn Dryer; Mark Gajjar; Nikhil Narang; Margaret Lee; Jonathan Paul; Atman P Shah; Sandeep Nathan; Javed Butler; Charles J Davidson; William F Fearon; Sanjiv J Shah; John E A Blair
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-09       Impact factor: 4.733

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 5.  Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain.

Authors:  Sara I Graves; Darren J Baker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-03-23       Impact factor: 4.080

Review 6.  Mechanisms of Vascular Aging.

Authors:  Zoltan Ungvari; Stefano Tarantini; Anthony J Donato; Veronica Galvan; Anna Csiszar
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 7.  Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?

Authors:  Islam Y Elgendy; Carl J Pepine
Journal:  Am J Med       Date:  2019-01-23       Impact factor: 4.965

Review 8.  Senescent cells: a therapeutic target for cardiovascular disease.

Authors:  Bennett G Childs; Hu Li; Jan M van Deursen
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

9.  Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.

Authors:  Jasleen Ghuman; Xuan Cai; Ravi B Patel; Sadiya S Khan; Jonathan Hecktman; Margaret M Redfield; Gregory Lewis; Sanjiv J Shah; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal:  J Card Fail       Date:  2020-10-07       Impact factor: 5.712

Review 10.  Senescence mechanisms and targets in the heart.

Authors:  Maggie S Chen; Richard T Lee; Jessica C Garbern
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.